Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $297 billion, the company also provides veterinary pharmaceuticals, vaccines and health management solutions and services.
Companies with a market cap of $200 billion or more are typically referred to as “mega-cap stocks.” Jabil fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the general drug manufacturers industry.